Literature DB >> 10931011

Controversies surrounding the clonogenic origin of multiple myeloma.

F E Davies, A C Rawstron, R G Owen, G J Morgan.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10931011     DOI： 10.1046/j.1365-2141.2000.02072-6.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  Novel analysis of clonal diversification in blood B cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis.

Authors:  Roshini S Abraham; Michelle K Manske; Neta S Zuckerman; Abhishek Sohni; Hanna Edelman; Gitit Shahaf; Michael M Timm; Angela Dispenzieri; Morie A Gertz; Ramit Mehr
Journal:  J Clin Immunol       Date:  2006-12-28       Impact factor: 8.317

2.  CD52 is not a promising immunotherapy target for most patients with multiple myeloma.

Authors:  Jörg Westermann; Georg Maschmeyer; Antje van Lessen; Bernd Dörken; Antonio Pezzutto
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 3.  Chimeric antigen receptor T-cell therapies for multiple myeloma.

Authors:  Lekha Mikkilineni; James N Kochenderfer
Journal:  Blood       Date:  2017-09-19       Impact factor: 22.113

4.  A reappraisal of immunoglobulin variable gene primers and its impact on assessing clonal relationships between PB B cells and BM plasma cells in AL amyloidosis.

Authors:  Nagaaki Katoh; Tanya L Poshusta; Michelle K Manske; Angela Dispenzieri; Morie A Gertz; Roshini S Abraham; Marina Ramirez-Alvarado
Journal:  J Clin Immunol       Date:  2011-09-10       Impact factor: 8.317

5.  Characterization of clonogenic multiple myeloma cells.

Authors:  William Matsui; Carol Ann Huff; Qiuju Wang; Matthew T Malehorn; James Barber; Yvette Tanhehco; B Douglas Smith; Curt I Civin; Richard J Jones
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

6.  Insertional hypermutation in mineral oil-induced plasmacytomas.

Authors:  Gero Knittel; Mirjam Metzner; Gabriele Beck-Engeser; Ada Kan; Tomasz Ahrends; Dan Eilat; Konrad Huppi; Matthias Wabl
Journal:  Eur J Immunol       Date:  2014-09       Impact factor: 6.688

7.  Clonogenic multiple myeloma cells have shared stemness signature associated with patient survival.

Authors:  Renji Reghunathan; Chonglei Bi; Shaw Cheng Liu; Koh Tze Loong; Tae-Hoon Chung; Gaofeng Huang; Wee Joo Chng
Journal:  Oncotarget       Date:  2013-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.